Acquisition Update: Entero Healthcare Acquires 51.5% Stake in Anand Chemiceutics

Kiran DSIJCategories: Mindshare, Trendingjoin us on whatsappfollow us on googleprefered on google

Acquisition Update: Entero Healthcare Acquires 51.5% Stake in Anand Chemiceutics

By integrating Anand Chemiceutics—a veteran distributor with over twenty years of expertise—Entero gains access to a robust network of more than 1,500 hospitals, laboratories and government institutions across India.

Entero Healthcare Solutions Limited has officially completed the acquisition of a 51.5 per cent stake in Anand Chemiceutics, a move that significantly broadens its footprint within the high-growth MedTech and diagnostic sectors. By integrating Anand Chemiceutics—a veteran distributor with over twenty years of expertise—Entero gains access to a robust network of more than 1,500 hospitals, laboratories and government institutions across India. This partnership is designed to capitalise on collective distribution strengths and technical proficiency, particularly in specialised areas like advanced genomics and turnkey solutions for healthcare facilities.

The strategic alignment, initially announced in late 2025, is a pivotal step in Entero’s mission to build an integrated healthcare supply chain. With the addition of Anand Chemiceutics’ specialised capabilities in equipment marketing and service support, the MedTech segment is projected to contribute over Rs 1,000 crore in annualised revenue during the upcoming financial year. This acquisition not only scales Entero’s geographic reach but also reinforces its role as a comprehensive provider capable of meeting the evolving technical demands of the Indian healthcare market.

Spot tomorrow’s giants today with DSIJ’s Tiny Treasure, a service identifying high-potential Small-Cap companies poised for growth. Get the Full Brochure

About the Company

Entero Healthcare Solutions Ltd (Entero) is one of India’s leading and fastest-growing healthcare products distribution platforms. Established in 2018, Entero has rapidly scaled to become a key player in the pharmaceutical supply chain. Driven by a proprietary technology platform, Entero enables seamless integration of data intelligence, demand generation and fulfilment solutions. Through its flagship B2B app, Entero Direct, the company delivers real-time inventory visibility, efficient order management and tailored customer engagement tools. Entero’s commitment to operational excellence is supported by its experienced leadership team, a healthcare-focused investor base and a relentless pursuit of innovation. By combining a customer-centric approach with advanced Logistics infrastructure, Entero is reshaping India’s fragmented healthcare distribution landscape, ensuring accessibility, affordability and efficiency in healthcare delivery.

Disclaimer: The article is for informational purposes only and not investment advice.